CN112851575A - Ratio type lysosome pH probe with aggregation-induced emission property and application - Google Patents
Ratio type lysosome pH probe with aggregation-induced emission property and application Download PDFInfo
- Publication number
- CN112851575A CN112851575A CN201911101156.8A CN201911101156A CN112851575A CN 112851575 A CN112851575 A CN 112851575A CN 201911101156 A CN201911101156 A CN 201911101156A CN 112851575 A CN112851575 A CN 112851575A
- Authority
- CN
- China
- Prior art keywords
- aie
- lysosomes
- luminophore
- csmpp
- lysosomal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003712 lysosome Anatomy 0.000 title claims abstract description 58
- 230000001868 lysosomic effect Effects 0.000 title claims abstract description 58
- 239000000523 sample Substances 0.000 title claims abstract description 40
- 230000002776 aggregation Effects 0.000 title abstract description 9
- 238000004220 aggregation Methods 0.000 title abstract description 9
- 210000004027 cell Anatomy 0.000 claims abstract description 50
- 241000251468 Actinopterygii Species 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 34
- 230000008929 regeneration Effects 0.000 claims abstract description 19
- 238000011069 regeneration method Methods 0.000 claims abstract description 19
- 230000008569 process Effects 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 230000002132 lysosomal effect Effects 0.000 claims description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000007774 longterm Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 230000008685 targeting Effects 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 230000004043 responsiveness Effects 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 3
- MFHFWRBXPQDZSA-UHFFFAOYSA-N 2-(4-bromophenyl)acetonitrile Chemical compound BrC1=CC=C(CC#N)C=C1 MFHFWRBXPQDZSA-UHFFFAOYSA-N 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical class ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 2
- 238000006000 Knoevenagel condensation reaction Methods 0.000 claims description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000012043 crude product Substances 0.000 claims description 2
- 239000003480 eluent Substances 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000012074 organic phase Substances 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000010898 silica gel chromatography Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- SSVFMICWXDVRQN-UHFFFAOYSA-N ethanol;sodium Chemical compound [Na].CCO SSVFMICWXDVRQN-UHFFFAOYSA-N 0.000 claims 1
- 210000004276 hyalin Anatomy 0.000 claims 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 19
- 238000009826 distribution Methods 0.000 abstract description 12
- 230000008859 change Effects 0.000 abstract description 10
- 238000000338 in vitro Methods 0.000 abstract description 4
- 102100028776 Centrosome and spindle pole-associated protein 1 Human genes 0.000 description 26
- 101000916452 Homo sapiens Centrosome and spindle pole-associated protein 1 Proteins 0.000 description 26
- 230000000366 juvenile effect Effects 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 241000276569 Oryzias latipes Species 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 238000002266 amputation Methods 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- 230000017423 tissue regeneration Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 238000011088 calibration curve Methods 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 238000002073 fluorescence micrograph Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 230000004900 autophagic degradation Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000005588 protonation Effects 0.000 description 5
- 241000252212 Danio rerio Species 0.000 description 4
- 229930191564 Monensin Natural products 0.000 description 4
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000013626 chemical specie Substances 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- DANUORFCFTYTSZ-UHFFFAOYSA-N epinigericin Natural products O1C2(C(CC(C)(O2)C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)C)C(C)C(OC)CC1CC1CCC(C)C(C(C)C(O)=O)O1 DANUORFCFTYTSZ-UHFFFAOYSA-N 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 4
- 229960005358 monensin Drugs 0.000 description 4
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 4
- DANUORFCFTYTSZ-BIBFWWMMSA-N nigericin Chemical compound C([C@@H]1C[C@H]([C@H]([C@]2([C@@H](C[C@](C)(O2)C2O[C@@](C)(CC2)C2[C@H](CC(O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C)O1)C)OC)[C@H]1CC[C@H](C)C([C@@H](C)C(O)=O)O1 DANUORFCFTYTSZ-BIBFWWMMSA-N 0.000 description 4
- 230000001172 regenerating effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229960001603 tamoxifen Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- -1 N-methylpiperazinyl Chemical group 0.000 description 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
- 230000031018 biological processes and functions Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 102000034287 fluorescent proteins Human genes 0.000 description 3
- 108091006047 fluorescent proteins Proteins 0.000 description 3
- 238000004770 highest occupied molecular orbital Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000007309 lysosomal acidification Effects 0.000 description 3
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
- 239000006174 pH buffer Substances 0.000 description 3
- 125000004193 piperazinyl group Chemical group 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- IYXVSRXFGYDNEV-UHFFFAOYSA-N 3-phenylprop-2-ynenitrile Chemical group N#CC#CC1=CC=CC=C1 IYXVSRXFGYDNEV-UHFFFAOYSA-N 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 2
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
- 102000003669 Antiporters Human genes 0.000 description 2
- 108090000084 Antiporters Proteins 0.000 description 2
- 238000003775 Density Functional Theory Methods 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004957 autophagosome Anatomy 0.000 description 2
- XDHNQDDQEHDUTM-JQWOJBOSSA-N bafilomycin A1 Chemical compound CO[C@H]1\C=C\C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@]1(O)O[C@H](C(C)C)[C@@H](C)[C@H](O)C1 XDHNQDDQEHDUTM-JQWOJBOSSA-N 0.000 description 2
- XDHNQDDQEHDUTM-ZGOPVUMHSA-N bafilomycin A1 Natural products CO[C@H]1C=CC=C(C)C[C@H](C)[C@H](O)[C@H](C)C=C(C)C=C(OC)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@]1(O)O[C@H](C(C)C)[C@@H](C)[C@H](O)C1 XDHNQDDQEHDUTM-ZGOPVUMHSA-N 0.000 description 2
- XDHNQDDQEHDUTM-UHFFFAOYSA-N bafliomycin A1 Natural products COC1C=CC=C(C)CC(C)C(O)C(C)C=C(C)C=C(OC)C(=O)OC1C(C)C(O)C(C)C1(O)OC(C(C)C)C(C)C(O)C1 XDHNQDDQEHDUTM-UHFFFAOYSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000009878 intermolecular interaction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 238000000103 photoluminescence spectrum Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 150000004763 sulfides Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 238000012301 transgenic model Methods 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical group C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N DMSO-d6 Substances [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 description 1
- 108010083204 Proton Pumps Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000015505 Sorghum bicolor subsp. bicolor Nutrition 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004908 autophagic flux Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000010001 cellular homeostasis Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000004773 frontier orbital Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000010039 intracellular degradation Effects 0.000 description 1
- 230000012105 intracellular pH reduction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000021962 pH elevation Effects 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010823 ratiometric pH measurement Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035440 response to pH Effects 0.000 description 1
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The present invention relates to a simple method for the preparation of luminophores (AIEgens) that test the pH of lysosomes and have aggregation-induced emission (AIE). The present invention relates to a ratiometric pH probe that can test for pH in the maximum range of pH between 3 and 6.5. The AIE luminophores provided by the invention can quantitatively test the pH of lysosomes in cells in vitro, and can also test the pH of lysosomes in living small fish. The AIE luminophor provided by the invention can also track the detailed change process of the average lysosome pH and the distribution condition of the lysosome pH in the regeneration process of the small fish tail fin for a long time, and provides a simple, convenient and effective method for observing the regeneration process.
Description
Technical Field
The invention relates to a simple method for preparing a luminophore (AIEgenes) for testing the lysosome pH and having aggregation-induced emission (AIE), to the use of said luminophore as a pH probe of the ratiometric type, and to the use of said luminophore for long-term tracking of the lysosome pH changes during the regeneration of the tail fins of small fish.
Background
Tissue regeneration refers to the process by which an organism undergoes self-renewal and self-repair following injury to regrow a damaged or lost body part. Although humans have some regenerative capacity, for example, skin, fingertips, endometrium and liver can regenerate naturally, this capacity is dwarfed by the regenerative capacity of vertebrates such as lizards, zebrafish, xenopus laevis, etc. In order to promote the development of regenerative medicine, researchers have made many efforts in studying biological processes associated with tissue regeneration using vertebrate transgenic models. Among them, zebrafish and medaka are vertebrate models that are widely used because they can regenerate many organs, for example, the central nervous system, heart, kidney, and especially their tail fins can have unlimited regeneration potential after amputation. And they are excellent transgenic models that can be used to understand the mode of occurrence and the cause of tissue regeneration. In addition, they are easy to raise in the laboratory and have a transparent body in the early stages of life, so that in vivo tissues can be easily imaged in real time without sacrificing the subject.
To study the biological processes in tissue regeneration, the most popular approach for biologists is to use transgenic fluorescent fish with fluorescent protein-tagged proteins. Although transgenic technology of fluorescent protein fusion offers the possibility to study protein kinetics in living cells. However, this technique is complex, time consuming, expensive and prone to photobleaching. Furthermore, the macromolecular size of the fluorescent protein may affect the function of the fusion protein of interest. Another popular method of investigation is fluorescence immunohistochemical staining. It requires the fixation and permeabilization of the cells, which may lead to some drawbacks, such as protein extraction or translocation, blocking of protein epitopes and inability to image in real time, thus possibly leading to information on some biological processes that are erroneous or missing. Therefore, a simple method is urgently required. The method allows direct observation of the tissue regeneration process in real time to further validate the biological changes that are generally accepted but not fully revealed in the caudal fin regeneration process.
Lysosomes are "waste disposal systems" for cells. As they are responsible for intracellular degradation of substances (e.g., damaged organelles, used proteins, DNA, phospholipids, etc.) and release metabolites and ions to maintain cellular homeostasis. Therefore, they are involved in many important cellular processes and disease pathogenesis. Among the most important functions of lysosomes are their involvement in autophagy, a process mediated by the lysosome in the autophagy of eukaryotic cells, which is essential for tissue regeneration. Lysosomal pH is an important parameter indicative of lysosomal hydrolase activity and lysosomal functional status. To perform the normal function of lysosomes, the pH of the lysosome must be maintained within the acidic range of pH 4-5. This is because most lysosomal hydrolases of all classes have optimal activity at acidic pH values. In some cases, if the pH of the lysosome is not considered, erroneous conclusions may be drawn about the biological phenomenon. For example, an increase in the fluorescent protein-labeled LC3-II (tubulin light chain 3) protein recruited to the autophagosome membrane does not necessarily imply an increase in autophagy flux, as this may be due to blockade of lysosomal alkalinization leading to degradation of autophagosomes. Therefore, tracking lysosomal pH changes in real time can lead to a more comprehensive understanding of events in the tissue regeneration process, thereby promoting the development of regenerative medicine.
Probes suitable for use in tracking lysosomal pH during tissue regeneration need to meet the following requirements: (1) good light stability; (2) long-term tracking ability; (3) targeting lysosomes; (4) is sensitive to pH; (5) quantitatively measuring the pH; (6) in vivo non-invasive imaging.
Intensity-based fluorescent lysosomal pH probes are affected by many factors, including variations and maldistribution of probe concentration, temperature, environmental polarity, and fluctuations in excitation light. In contrast, ratiometric probes can overcome systematic errors and quantify more accurately. Conventional ACQ probes have a problem of fluorescence quenching at high concentrations or in an aggregated state due to strong pi-pi stacking, and thus, in biological applications, conventional ACQ probes are often suggested to be used at low concentrations. But this presents other problems such as being easily photobleached and not suitable for long-term tracking applications. In addition, their smaller stokes shift leads to strong self-absorption. The more AIE material compared to ACQ material, the brighter it is. Research over recent decades has demonstrated that AIEgens have high light stability, large stokes shift, excellent long-term trackability and good biocompatibility. Although research on tissue regeneration and lysosomes has been of great interest, there has been no study for monitoring lysosomal pH changes in real time during tissue regeneration in vivo. Therefore, there is an urgent need to develop ratiometric AIEgen probes for long-term follow-up of lysosomal pH changes during tissue regeneration in vivo.
Disclosure of Invention
In one embodiment, the present invention provides a luminophore exhibiting aggregation-induced emission, the luminophore comprising the following structure:
In one embodiment, the present application is directed to a aggregation-inducing luminophore (AIEgen) comprising: piperazine groups target lysosomes, pyridine groups act as pH-responsive groups, and AIEgen exhibits aggregation-induced emission properties.
Drawings
FIG. 1 shows CSPP1H NMR spectrum;
FIG. 2 shows CSPP13C NMR spectrum;
FIG. 3 shows a high resolution mass spectrometry (MALDI-TOF) plot of CSMPP;
FIG. 4a shows a single crystal structure of CSMCPP; FIG. 4b shows CSMCPP as a function of water volume fraction (f) in an acetonitrile/water mixed solventw) A PL spectrum resulting from the change in (c); FIG. 4c shows αAIEAnd fwAlpha is I/I0I and I0Are respectively represented inHaving fwIn a mixed solvent of acetonitrile/water and in pure acetonitrile at 509nm, the concentration of CSMPP is 10. mu.M, the excitation wavelength is 365nm, and the inset in FIG. 4c is under a hand-held UV lamp at 365nm, fw0% and fwFluorescence photograph of 90% CSMPP solution, the molecular structure of CSMPP is inserted in fig. 4 c;
FIG. 5a shows the PL spectra of CSMPP in glycerol/ethylene glycol mixed solvents of different volume fractions of glycerol; FIG. 5b shows I/I0Plot of volume fraction of glycerol, I and I0Represents the PL intensity at 494nm in a glycerol/ethylene glycol mixed solvent with a certain glycerol volume fraction and in pure ethylene glycol, respectively, the concentration of CSMPP is 10 μ M, and the excitation wavelength is 365 nm;
FIG. 6 shows intermolecular interactions in a CSMP single crystal structure;
FIG. 7 shows the reaction in DMSO-d6Before and after addition of excess deuterated hydrochloric acid solution (2.5 equivalents) to the solution, CSPP1H NMR spectrum;
FIG. 8 shows electron cloud profiles of HOMO and LUMO based on Frontier molecular orbitals optimized by M062X/6-31G (d, p) levels before and after CSMCP acidification;
FIG. 9a shows fluorescence emission spectra of CSMPP (10. mu.M) in buffer solution (containing 2% DMSO) at pH 2.60-6.80; FIG. 9b shows the fluorescence intensity ratio (I)615/I503) Graph with pH; the fluorescence pictures inserted in FIG. 9b are CSPP fluorescence pictures in different pH solutions under excitation of a hand-held 365nm UV lamp; FIG. 9c shows the ratio I615/I503),Rmin、RmaxA pH calibration curve is fitted with the relationship between the pH and the pH; FIG. 9d shows the reversibility of CSMCPP response to pH 7 and pH 3, showing PL intensity ratio (I)615/I503) Changes with the number of reciprocating cycles of pH; fig. 9e shows the interference of probe signals by different chemical species in buffers at pH 6.8 and pH 3.0, chemical species: (1) blank; (2) ca2+;(3)Mg2+;(4)Cd2+;(5)Co2+;(6)Fe2+;(7)Fe3+;(8) Ni2+;(9)Cu2+;(10)Al3+;(11)Zn2+;(12)Ag+;(13)Mn2 +;(14)Pb2+;(15) K+;(16)Na+;(17)I-;(18)HPO4 2-;(19)H2PO4 -;(20)Ac-;(21)NO3 -; (22)CO3 2-;(23)ClO-;(24)HS-;(25)SCN-;(26)S2O3 2-;(27)H2O2(ii) a (28) Tryptophan; (29) (ii) glutamine; (30) aspartic acid; (31) glycine; (32) leucine; (33) valine; (34) (ii) cysteine; (35) homocysteine; (36) glutathione; (37) arginine; (38) serine; (39) glucose; and (3) testing conditions are as follows: the probe concentration was 10. mu.M; the concentration of the reagent 1-14 is 0.2 mM; the concentration of the reagent 15-39 is 1 mM; all anions of the cation being Cl-But NO3-For Ag+、Mn2+And Pb2+An anion of (a); all anions have a cation of Na+,λexThe fluorescence emission at wavelengths of 503nm and 615nm was recorded at 365 nm;
FIG. 10 shows a plot of fluorescence intensity at 615nm as a function of pH; when PL intensity was changed by half, the corresponding pH represented pKaThe pK calculated therefroma4.75 +/-0.02;
FIG. 11 shows the absorption spectrum after normalization of CSMP in buffers at pH 6.8 and pH 2.6, and the corresponding structural formula of CSMP at pH 6.8 and pH 2.6;
FIG. 12 shows confocal images of laser staining of HeLa cells with 200nM LysoTracker Red (LTR) for 10 min followed by co-staining with 2 μ M CSPP for 10 min; FIG. 12a is a fluorescence image of CSMCPP; FIG. 12b is a fluorescent picture of LTR; FIG. 12c is a picture of a and b merged; FIG. 12d is a picture with a and b merged with a bright field; FIG. 12e is the signal distribution of the green channel of CSMPP and the red channel of LTR; FIG. 12f is a fluorescence intensity distribution curve extracted from the white arrow in FIG. 12 c; and (3) testing conditions are as follows: for CSMCP, lambdaex=405nm,λem580nm ═ 450-; for LTR, λex=560 nm,λ em650 and 700 nm. Scale bar is 10 μm;
FIG. 13 shows confocal images of ARPE-19 cells stained with 240nM LysoTracker Blue (LTB) for 10 min, then co-stained with 1.5. mu.M CSMPP for 10 min; FIG. 13a is a fluorescent photograph of CSMCP; FIG. 13b is a fluorescence image of LTB; FIG. 13c is a picture with a and b merged; FIG. 13d is a picture with a and b merged with a bright field; FIG. 13e is a signal distribution plot of the red channel of CSMCPP and the green channel of LTB; FIG. 13f is a fluorescence intensity distribution curve extracted from the white arrow in FIG. 13 c; and (3) testing conditions are as follows: for CSMCP, lambdaex=405nm,λem480 nm. For LTB, λex= 405nm,λem400-; scale bar is 10 μm;
figure 14 shows cell motility diagrams of (a) HeLa and (b) ARPE-19 cells after 24h incubation with different concentrations of CSMPP, giving data as mean ± SD (n ═ 4);
FIG. 15 shows (a) laser confocal images, λ, of the whole body of a medaka juvenile fish after being fed with 5 μ M CSMPP for 4 hoursex=405nm,λem468-; (b) after CSMCPP (5 mu M) and deep red LysoTracker (LTDR, 200nM) are used for feeding the medaka juvenile fish together, laser confocal images of tail fins of the medaka juvenile fish are sequentially fluorescence images of CSMCPP and LTDR, merged images of two channels and a bright field, merged images of two channels, amplified images cut from the merged images of the two channels and signal distribution maps of the two channels; and (3) testing conditions are as follows: for CSMCP, lambdaex=405nm,λem468 and 630 nm; for LTDR, λex=633nm,λem647 and 713 nm; the scale bar is 50 μm. The scale bar of the magnified image was 10 μm;
fig. 16 shows the biocompatibility of CSMPP for medaka juvenile fish: (a) survival measured after exposing juvenile fish to different concentrations of CSMPP for 96 hours; (b) mean heart beat of young fish at different times after feeding 5 μ M CSPP for 4 hours; each concentration treatment consisted of three replicate samples, each sample containing 10 individual juvenile fish, the heartbeat of 15 juvenile fish being recorded each time, the data being mean ± SD;
FIG. 17 shows (a) CSMPP, LTR and LThe change in fluorescence signal of TG-stained HeLa cells after continuous scanning with CLSM was mean ± SD (n ═ 4); (b) fluorescence pictures of HeLa cells stained for 12 min with 2 μ M CSMPP at the 1 st and 100 th scans; (c) fluorescence pictures of HeLa cells stained with 500nM LTR for 6 min and (d) with 500nM LTG for 5 min at 1 st and 50 th scans; for CSPP: lambda [ alpha ]ex=405nm;λ em470 and 650 nm; for LTR: lambda [ alpha ]ex=561nm,λ em565 and 650 nm; for LTG: lambda [ alpha ]ex= 488nm,λem495 and 580nm, and the scale bar is 20 μm;
FIG. 18 shows (a) a standard curve of HeLa cells photographed using CLSM with 63 fold oil lens and in which probes were tested; first staining the cells with 3. mu.M CSPP for 1h at 37 ℃ and then equilibrating the cells in pH buffer containing 12. mu.M nigericin and 5. mu.M monensin for 8 min at 25 ℃ to capture the fluorescence images of the green channel (470-560nm) and the red channel (560-700nm) of HeLa cells in different pH buffers; ratio images were acquired by dividing the red channel by the green channel using Image J software, with a scale bar of 20 μm; (b) em-red/Em-greenThe relation between the average ratio and the pH value, and the average value +/-SD is obtained from the three pictures; in addition, according to the average ratio, Rmin、RmaxAnd the relationship between the pH value and the pH value is fitted to obtain a calibration curve;
fig. 19 shows CLSM pictures after HeLa cells were stimulated with chemicals, including bright field, green channel, red channel, merged two-channel pictures, and distribution pictures of lysosomal pH; pictures are sequentially normal lysosomes without irritant effects; 50nM of effected lysosomes incubated with broomcorn A1 for 30 min at 37 ℃; 0.1mM H2O2Lysosomes after incubation at 37 ℃ for 30 minutes; lysosomes after incubation with 40 μ M Tamoxifen (TMX) for 15 minutes at 37 ℃; lysosomes after 8 min incubation with 1.75mM and 10mM acetic acid (HAc) at 37 ℃; analyzing the confocal fluorescence images of the red and green channels by Image J software to obtain ratio images; the scale bar is 20 μm, the excitation wavelength is 405nm, and the green channel of 470-560nm and the red channel of 560-700nm are collectedA fluorescent picture;
FIG. 20 shows (a) standard curves of zebrafish cells photographed using a CLSM with a 40-fold oil mirror and in which probes were tested; cells were first stained with 3. mu.M CSPP for 1h at 37 ℃ and then equilibrated at 25 ℃ for 8 min in pH buffer containing 12. mu.M nigericin and 5. mu.M monensin, lambdaex405 nm; green channel lambdaem416 and 555 nm; red channel lambdaem557 + 704 nm; ratio images were acquired by dividing the red channel by the green channel using Image J software, scale bar 50 μm; (b) em-red/Em-greenThe relation between the average ratio and the pH value, and the average value +/-SD is obtained from the three pictures; in addition, according to the average ratio, Rmin、RmaxAnd the relationship between pH was fitted to a calibration curve.
Fig. 21 shows laser confocal pictures of medaka juvenile tail fins before and after amputation at different times (12, 24, 48, 96 and 120 hpa), including brightfield, green channel, red channel, merged two-channel pictures, and distribution pictures of lysosomal pH; lambda [ alpha ]ex405 nm; green channel lambdaem416 and 555 nm; red channel lambdaem557 + 704 nm; analysis of E using Image J softwarem-red/Em-greenThe ratio image of (1); hours after amputation abbreviated hpa; the white dotted line represents the amputation plane; the light blue dotted line represents the small fin profile with a scale bar of 50 μm.
Fig. 22 shows the average pH change of lysosomes in medaka juvenile fish during tail fin regeneration; as a control to the amputated medaka juvenile fish, the non-amputated medaka juvenile fish takes the same time as it takes after being fed CSMPP; the times shown here are named according to the time after amputation; "0 h" refers to the time after CSMP feeding until amputation;
fig. 23 shows laser confocal pictures of tail fins of non-amputated medaka juvenile fish at different times after being fed with 5 μ M CSMPP 4h, including brightfield, green channel, red channel, merged two-channel pictures, and distribution pictures of lysosomal pH; lambda [ alpha ]ex405 nm; green channel lambdaem416 and 555 nm; red channel lambdaem557 + 704 nm; analysis of E using Image J softwarem-red/Em-greenScale bar of 50 μm.
Detailed Description
The present invention provides an AIEgen probe for ratiometric lysosomal pH, wherein a piperazine group is used for lysosomal targeting. The large changes in intramolecular charge transfer before and after protonation of the pyridine group allowed us to quantitatively test lysosomes for pH using a ratiometric method. In this application, one non-limiting example of an AIEgen design, in particular, is CSMPP. And one non-limiting application is to monitor the regeneration process of the tail fin of medaka juvenile fish by testing the lysosomal pH value of the tail fin near the amputation plane.
In one embodiment, the AIEgen of the present invention is a CSMPP having the structure:
in embodiments of the methods of synthesis of AIEgens according to the present application, the AIEgens can be ratiometric pH probes, can specifically target lysosomes in cells, have good photostability, good pH responsiveness, low cytotoxicity, low fish toxicity, and can track lysosomal pH changes during fin regeneration for long periods of time.
Synthesis of Compound CSPP
The starting material was prepared by Suzuki coupling followed by one-step Knoevenagel condensation to form CSMPP. Wherein the α -cyanobenzene is the core backbone that confers the characteristics of AIE. The synthetic route of CSMCPP is shown below.
Synthesis of Compound 3: to a 100mL two-necked round bottom flask equipped with a condenser were added 2- (4-bromophenyl) acetonitrile (compound 30, 0.50g, 2.55mmol), 4-pyridylboronic acid (compound 40; 0.31g, 2.55mmol), potassium carbonate (3.52g, 25.5mmol) and Pd(PPh3)4(35mg, 0.03mmol), 50mL of THF and 10mL of water were added to dissolve under nitrogen. The mixture was stirred and heated to reflux overnight. After cooling to room temperature, the mixture was extracted three times with Dichloromethane (DCM). The organic phase was collected, washed with water and dried over anhydrous sodium sulfate. After evaporation of the solvent, the crude product was purified by silica gel column chromatography using DCM/ethyl acetate (v/v ═ 99:1) as eluent to give the product as a white solid. Yield: 81 percent.1H NMR(400MHz, CDCl3),δ(ppm):8.69(d,2H,J=6.0Hz),7.67(d,2H,J=8.4Hz), 7.51-7.46(m,4H),3.83(s,2H).13C NMR(100MHz,CDCl3),δ(ppm): 149.7,146.7,137.5,130.2,128.1,127.1,120.9,116.9,22.9.HRMS (MALDI-TOF):m/z 194.0914(M+Theoretical value 194.0844).
Synthesis of Compound 5: 3(0.1g, 0.515mmol) and 4(0.105g, 0.515mmol) were placed in a 50mL round bottom flask and dissolved with 4mL ethanol. Sodium hydroxide (20.6mg, 0.515mmol) was dissolved in 1mL ethanol and then slowly added to the mixture. After stirring for 2 hours at room temperature, the pale yellow precipitate was filtered off, washed with cold ethanol and dried under reduced pressure. Yield of the product: 80 percent. Crystals of CSPP were obtained by slowly volatilizing a nearly saturated chloroform solution thereof.1H NMR(400MHz, CDCl3),δ(ppm):8.76-8.60(m,2H),7.90-7.83(m,2H),7.74(d,J= 8.6Hz,2H),7.68(d,J=8.5Hz,2H),7.55-7.49(m,2H),7.47(s, 1H),7.01-6.84(m,2H),3.45-3.29(m,4H),2.56(t,J=5.1Hz,4H), 2.35(s,3H).13C NMR(400MHz,CDCl3),δ(ppm):δ152.47, 150.33,147.25,142.52,137.73,136.05,131.32,127.46,126.19, 123.69,121.36,118.82,114.36,105.32,54.73,47.36,46.13.HRMS (MALDI-TOF):m/z 381.2085(M+Theoretical value 380.2001).
AIE Properties of CSPP
The photophysical properties of CSMPP were first studied. In the good solvent acetonitrile, CSMPP has very weak emission with a maximum emission wavelength of 509nm, at which the absolute fluorescence quantum yield is 0.8%. With the water content (f) in the mixed solvent of acetonitrile and waterw) Is gradually increased at fwBelow 80%, CSMP fluorescence emission is very weak and essentially unchangedTo reduce to 80% fwThereafter, the fluorescence increases dramatically due to the restriction of intramolecular movement by the aggregates produced (FIGS. 4b and 4 c). At 90% fwMaximum fluorescence emission at time of about 0% f w7 times of the time. Thus, the change in fluorescence after gradually increasing the poor solvent water indicates that CSPP has AIE properties. In addition, the absolute fluorescence quantum yield of CSPP powder reaches 25.4%, and the emission peak is at 525 nm.
Similarly, under high viscosity conditions, intramolecular motion may also be restricted to excite the radiation channel. As shown in FIG. 5, the CSPP fluorescence emission gradually increased with increasing glycerol content in the glycerol and ethylene glycol mixture. And the quantum yield of CSPP reaches 10.5% in the solution containing 95% glycerol.
To further understand the AIE properties of CSMPP, its single crystal structure was studied (fig. 4 a). The molecule has a slightly distorted conformation with dihedral angles of 10.95 ° and 11.08 °. Therefore, the benzene ring adjacent to the acrylonitrile group can freely rotate in a good solvent, thereby consuming energy of the exciton in a non-radiative manner. When the molecules are in an aggregated state or in a high viscosity solution, the process of restricting intramolecular movement can be activated, thereby enabling the molecules to have a strong light-emitting ability. It was found from the alignment of the crystals that the course of RIM is caused by the intermolecular interactions of C-H. And J-aggregates were observed in the stacking of single crystals (FIG. 6), without strong pi-pi stacking effect.
Mechanism research of pH responsiveness of CSPP
To investigate the pH responsiveness of CSMP, this study tested DMSO-d in CSMP6Before and after adding deuterated hydrochloric acid to the solution1H NMR spectrum. The results are shown in FIG. 7, where H in the methyl group on the piperazinyl group and H next to the pyridyl group undergo significant low field shift, indicating that both N-methylpiperazinyl and pyridyl can be protonated. Due to pK of N-methylpiperidine and pyridinea10.08 and 5.23 respectively, CSMPP has two groups of weak bases enabling it to target lysosomes with acidic pH.
To understand the photophysical properties of CSPP before and after acidification, the study was based on CSPPThe Frontier molecular orbits of the ground state were calculated by the Density Functional Theory (DFT). The results are shown in FIG. 8, CSMCPP-H+(N-methyl-piperazinyl is protonated) and CSMCPP-2H+(both the N-methyl-piperazinyl and the pyridine group are protonated), the electron clouds in the Highest Occupied Molecular Orbital (HOMO) of the three are located substantially around the cyanophenylacetylene. CSMCPP and CSMCPP-H+Is also predominantly located around the cyanophenylacetylene. While CSMCPP-2H+The electron cloud in LUMO of (a) is localized to the pyridylphenyl site. In addition, CSPP-H compares to neutral CSPP molecules+The HOMO-LUMO energy gap variation of (a) is negligible. However, CSMCPP-2H+The HOMO-LUMO gap (4.64eV) is smaller than that of CSPP (5.47 eV). This indicates that intramolecular charge transfer becomes more pronounced after the pyridyl group is protonated, which will cause a red shift in absorption and emission. This is the basis for the CSMP to have ratiometric pH testing properties.
Properties of CSPP Rate-type pH test
PL profiles of CSPP were measured in buffers of varying pH in the range of pH 2.60-6.80. As a result, as shown in FIG. 9, when the pH was decreased from pH 6.80 to pH 2.60, the fluorescence at the maximum emission peak 503nm gradually decreased, while a new emission peak appeared at 615nm, and the fluorescence gradually increased. An isoluminescent point was observed at 560nm, indicating that the conversion between the two luminescent substances occurred in the system. Meanwhile, when the pH was decreased from 6.80 to pH 3.45, the fluorescence image of the probe solution showed a distinct color change, i.e., from green to yellow and then red (inset in fig. 9 b). Further, the ratio of fluorescence emission at two wavelengths (I)615/I503) The curve with pH shows an inverse "S" shape and can be well fitted by the DoseResp function of Origin software (fig. 9 b). According to the following formula
After calculation, log [ (R-R) is obtainedmin)/(Rmax-R)]Linear relationship with pH (fig. 9 c). This indicates that the probe mayFor ratiometric pH measurements. In addition, the absolute pK exhibited by the probeaAt 4.75 ± 0.02 (fig. 10), just in the acidity window of the lysosome (pH 4.5-5.5), indicating that the probe is able to measure the pH of the lysosome.
After protonation, the absorption of CSPP was also red-shifted, with the maximum absorption peak changing from 353nm at pH 6.8 to 383nm at pH 2.6 (FIG. 11). Thus, the enhancement of intramolecular charge transfer after CSMCP protonation causes a significant red shift in the absorption spectrum (30nm) and emission spectrum (112 nm).
pH response reversibility and specificity of CSMP probes
The pH reversibility of CSMPP was checked by alternating the pH of the solution between pH 7 and pH 3 (fig. 9 d). As a result, it was found that the probe can emit fluorescence normally even after 5 cycles of the alkaline-acidic pH. Since the selectivity of the assay is crucial for pH measurements both in vivo and in vitro, the present invention investigates the interference of different chemical species on the binding of the probe to protons. As a result, as shown in FIG. 9e, the fluorescence ratios I of the probe solutions at pH 6.8 and pH 3.0, to which 38 kinds of chemicals possibly existing in the living system were added, respectively615/I503The changes are all minor. The 38 chemical species include metal ions (K)+,Na+,Ca2+,Mg2+,Cd2+,Co2+,Fe2+,Fe3+,Ni2+,Cu2+, Al3+,Zn2+,Ag+,Mn2+,Pb2+) Common anions (HPO)4 2-,H2PO4 -,Ac-, NO3 -,I-,CO3 2-) Active oxygen species (ClO)-,H2O2) Reactive sulfides (HS)-, SCN-,S2O3 2-Cysteine, homocysteine, glutathione), some natural amino acids and glucose. Thus, the probe can be used for specific pH tests without interference from certain common chemicals in living systems.
Targeting of CSPP to lysosomes in cells and cytotoxicity thereof
It is well known that HeLa cells are the most widely used cell model, while ARPE-19 cells (a human retinal pigment epithelium) are commonly used as an in vitro model of age-related macular degeneration. The present invention investigated the lysosome specific staining of CSMPP in vitro using HeLa cells and ARPE-19 cells and photographed with a Confocal Laser Scanning Microscope (CLSM). Results of co-staining HeLa cells with LysoTracker Red (LTR) and CSMPP showed that their signals overlapped well and the Pearson correlation coefficient was 0.92 (FIG. 12). Co-staining of ARPE-19 cells with LysoTracker Blue (LTB) and CSMPP also showed a higher Pearson correlation coefficient (0.90) (FIG. 13). Thus, CSPP stains acidic organelles as well as LysoTracker excellently.
The cytotoxicity of CSMPP on HeLa cells and ARPE-19 cells was investigated by the MTT method. The MTT results showed that when the CSMPP concentration did not exceed 10 μ M, the cell viability of HeLa cells remained above 91% (fig. 14a) and that of ARPE-19 cells remained above 80% (fig. 14 b). Thus, CSMPP has low cytotoxicity at staining concentrations below 10 μ M.
Targeting of CSMPP to lysosomes in vivo and its biocompatibility
The invention researches the lysosome specific imaging of the tail fin of the medaka juvenile fish. After feeding the young fish with CSMPP for 4 hours, the whole body of the young fish was illuminated with fluorescence (fig. 15 a). Most importantly, its tail fin is also illuminated. We here focused on studying specific imaging of lysosomes on the tail fin. After feeding young fish with CSMPP and LysoTracker deep (LTDR), images of the tail fin were captured using confocal laser microscopy (fig. 15 b). The results show that CSMP and LTDR overlap well with a Pearson correlation coefficient of 0.8 (FIG. 15 b). Thus, CSMPP targets lysosomes in the tail fin of juvenile fish as well as LTDR.
The biocompatibility of CSMPP to medaka juvenile fish is evaluated by adopting two methods. The first method exposes medaka juvenile fish to different concentrations of CSMPP (0-10. mu.M) for 96h, and the survival rate of the juvenile fish is recorded (FIG. 16 a). The second method monitors the change in the heart rate of a medaka juvenile fish after exposure to 5 μ M CSMPP for 4 hours later within 96 hours (fig. 16 b). The results show that the survival rate of young fish is over 80% when the CSMPP concentration does not exceed 10. mu.M (FIG. 16 a). The heart rate of the young fish remained almost unchanged for 96 hours after the young fish stopped exposure to CSMPP (fig. 16 b). Therefore, these results indicate that CSMPP has better biocompatibility with medaka juvenile fish.
Photostability of CSPP
For applications where imaging is to be tracked over a long period of time, photostability is a requirement for fluorescence imaging. The present invention investigated the photostability of CSMPP by scanning stained HeLa cells 100 times consecutively (fig. 17). For comparison, the light stability of LTR and LysoTracker Green (LTG) was also tested. The results show that the fluorescence signals of LTR and LTG are reduced to almost zero after 50 scans (FIGS. 17a and 17 b). Whereas the fluorescence signal of CSMPP remained above 80% even after 100 consecutive scans (fig. 17a and 17b), indicating that CSMPP has good photostability.
CSMP test for pH of lysosomes in cells following chemical stimulation
Before monitoring lysosomal pH changes in living cells, a pH calibration curve for CSMPP in HeLa cells was established. By means of H+/K+Antiporter nigericin and H+/Na+The pH standard curve was tested by reverse transport of monensin to homogenize the pH inside and outside the cell. Fig. 18 shows fluorescence ratio images at different pH values and pH calibration curves. To evaluate the performance of CSMPP to measure lysosomal pH, the present invention used some common chemical stimuli to adjust lysosomal pH and calculated the lysosomal pH based on the pH calibration curve (fig. 19). It is known that bafilomycin A1 can inhibit vacuole type H+ATPase (proton pump) to prevent protonation of lysosomes, thereby raising the pH of the lysosome. When CSMPP-stained HeLa cells were incubated with 50nM of bafilomycin a1 for 30 minutes, the lysosomal pH rose to 5.65 (fig. 19), while the normal lysosomal pH was 5.06 (fig. 19). Acetic acid is a weak organic acid that can diffuse freely into cells. After incubating HeLa cells with 10mM acetic acid for 8 min, the pH of the lysosome was reduced to 3.97 (fig. 19). Furthermore, it showed concentration-dependent cellular acidification in HeLa cells with 1.75mM acetic acidAfter 8 minutes of incubation, the pH of its lysosome was reduced to 4.45 (fig. 19). H2O2Is a reactive oxygen species that can exert oxidative stress on cells and damage vacuole type H+ATPase, leading to the basification of lysosomes. With 0.1mM H2O2After 30 minutes of treatment of HeLa cells, the lysosome pH rose to 5.55 (fig. 19). It is well known that tamoxifen can alkalify the pH of lysosomes, which rises to 6.14 after HeLa cells are incubated with 40 μ M tamoxifen at 37 ℃ for 15 minutes (fig. 19). Thus, these results indicate that CSMPP probes can sensitively monitor and quantify lysosomal pH in living cells.
Tracking of CSMCPP on lysosome pH in medaka juvenile fish tail fin regeneration process
Since the photographing conditions of the tail fin of the juvenile fish are different from those of the HeLa cell, the pH standard curve needs to be re-established. The pH standard curve was tested using CLSM with a 40x oil lens and zebrafish cells under the same conditions as tail fin photographing conditions. By means of H+/K+Antiporter nigericin and H+/Na+Backward transport of monensin to homogenize the pH inside and outside the cells, fluorescence ratio images of fish cells at different pH were obtained (E)m-red/Em-green) And a pH calibration curve. As shown in FIG. 20, the ratio of the mean fluorescence intensities of the two emission channels excited at 405nm (E) increases with increasing buffer pHm-red/Em-green) Exhibits an inverse "S" curve over a pH range of 2.5 to 7.0, from which R can be obtainedminAnd Rmax(FIG. 20 b). In addition, log [ (R-R)min)/(Rmax-R)]Linear relationship with pH between 3.0 and 6.5 (fig. 20b), which will be used to calculate lysosomal pH of the tail fin.
In the process of regeneration of the tail fin of the medaka juvenile fish, the change of the lysosome pH is tracked by using the CSMPP probe. The juvenile fish were fed with 5 μ M CSMPP for 4 hours and then their tail fins were truncated. Tail fin regeneration was followed using CSLM and tail fins of the same juvenile fish were photographed 12, 24, 48, 96 and 120 hours before and after amputation. Here several hours after amputation, abbreviated hpa. As a result, as shown in fig. 21, at 12hpa, the end of the tail fin, which was originally round, became a clean cut surface after being cut by a sharp scalpel. Then, the tail fin gradually regenerates. At 120hpa, the end of the tail fin became almost rounded and the tail fin reached almost the original length, indicating that the amputated tail fin is about to fully regenerate as it did the original tail fin. During regeneration, the lysosomal pH of the tail fin varies greatly. As shown in figure 22, the average lysosomal pH gradually decreased after amputation, reaching a minimum pH at 24-48hpa, which was reported to be the stage of blast formation. At 24hpa, the average lysosomal pH value decreased from the original pH of 5.1 to pH 4.6, for a total decrease of about 0.5. This indicates that lysosomes are most active at this stage. Regeneration at this stage relies primarily on autophagy to remove damaged tissue and cellular debris resulting from the injury. Thus, to aid autophagic degradation, lysosomal acidification of the cell is upregulated. Furthermore, at 24 and 48hpa (fig. 21), the pH distribution results for lysosomes indicate that lysosomes (including regenerated tissue) around the plane of the amputation are more acidic than lysosomes away from the plane of the amputation. Then, the average pH of the lysosomes was elevated after 48hpa and returned to near normal levels after 120hpa (fig. 22). Meanwhile, the pH of lysosomes in the tail fin of medaka juvenile fish hardly changed during the five-day follow-up without amputation (fig. 22 and 23).
In addition, autophagy was found to be activated, and V-ATPase expression and lysosomal acidification were upregulated during tissue regeneration. Our studies not only provided good support for previous studies on lysosome acidification during regeneration, but also showed a detailed course of changes in mean lysosomal pH and distribution of lysosomal pH during tail fin regeneration by a simpler method.
Given only as a non-limiting example herein, it is believed that the lysosomal pH probes designed by this invention can be used in a variety of biological tracking applications.
The implementation of the invention can achieve the following beneficial effects:
1. the preparation of the lysosome probe only needs two steps, and the method is simple.
2. The ratiometric pH probes of the invention can test for pH in the maximum range of pH between 3 and 6.5.
3. The lysosomal probes of the invention can not only target lysosomes, but also test lysosomal pH by the ratiometric method. Only one excitation light is needed to receive the fluorescence emission of two wave bands. The exciting light of 405nm is the light source of common microscope, and has wide application range. And the emission wavelength change before and after probe protonation is 112 nm. This large variation in emission wavelength allows flexibility in the choice of the range of the receive band relative to conventional dyes with small variations in emission shift.
4. The probe is a luminophore (AIEgenes) with aggregation-induced emission (AIE), so that the probe has the advantages of common AIEgenes, such as no quenching of aggregation fluorescence, good light stability, suitability for long-term tracking application and large Stokes shift.
5. The probe of the invention can not only quantitatively test the pH of lysosomes in vitro cells, but also test the pH of lysosomes in living small fish.
6. The probe can track the detailed change process of the average pH of the lysosome and the distribution condition of the pH of the lysosome in the regeneration process of the small fish tail fin for a long time, and provides a simple, convenient and effective method for observing the regeneration process.
7. The lysosomal pH probes designed by the present invention can be used in a variety of other biological tracking applications.
While the present invention has been described with reference to the embodiments shown in the drawings, the present invention is not limited to the embodiments, which are illustrative and not restrictive, and many modifications may be made by those skilled in the art without departing from the spirit and the scope of the present invention as defined in the appended claims.
Claims (7)
2. The AIE luminophore of claim 1, wherein said AIE luminophore exhibits pH responsiveness.
3. Use of the AIE luminophore of claim 1 for ratiometric lysosomal pH probes.
4. Use of the AIE luminophore of claim 1 for specific targeting to lysosomes in cells and small fish tail fin lysosomes.
5. Use of the AIE luminophore of claim 1 for long term tracking of lysosomal pH changes during fin regeneration in small fish.
6. Use of the AIE luminophore of claim 1 for long term tracking of the regeneration process of hyaline organisms.
7. A method for preparing the AIE luminophore of claim 1, wherein the AIE luminophore is synthesized by the following route:
the preparation method comprises the following steps:
preparation of starting material 3 by Suzuki coupling:
to a 100mL two-necked round bottom flask equipped with a condenser was added 2- (4-bromophenyl) acetonitrile, 4-pyridylboronic acid, potassium carbonate, and Pd (PPh)3)4Adding 50mL of THF and 10mL of water for dissolving under the protection of nitrogen; the mixture was stirred and heated to reflux overnight; is cooled toAfter room temperature, the mixture was extracted three times with dichloromethane; the organic phase was collected, washed with water and dried over anhydrous sodium sulfate; after evaporation of the solvent, the crude product was purified by silica gel column chromatography using DCM/ethyl acetate as eluent to give product 3 as a white solid;
forming the AIE luminophore by Knoevenagel condensation comprising:
placing compounds 3 and 4 in a 50mL round bottom flask, and dissolving with ethanol; sodium hydroxide was dissolved in 1mL of ethanol and then slowly added to the mixture; after stirring for 2 hours at room temperature, the pale yellow precipitate was filtered off, washed with cold ethanol and dried under reduced pressure; the AIE luminophores were obtained by slowly volatilizing a nearly saturated chloroform solution thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911101156.8A CN112851575B (en) | 2019-11-12 | 2019-11-12 | Ratio type lysosome pH probe with aggregation-induced emission property and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911101156.8A CN112851575B (en) | 2019-11-12 | 2019-11-12 | Ratio type lysosome pH probe with aggregation-induced emission property and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112851575A true CN112851575A (en) | 2021-05-28 |
CN112851575B CN112851575B (en) | 2022-07-15 |
Family
ID=75984561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911101156.8A Active CN112851575B (en) | 2019-11-12 | 2019-11-12 | Ratio type lysosome pH probe with aggregation-induced emission property and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112851575B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109313135A (en) * | 2016-07-21 | 2019-02-05 | 香港科技大学 | Aggregation-induced emission body for imaging cancerous |
CN109422707A (en) * | 2017-08-25 | 2019-03-05 | 香港科技大学 | Aggregation-induced emission lysosome probe and the preparation method and application thereof independent of acid pH |
-
2019
- 2019-11-12 CN CN201911101156.8A patent/CN112851575B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109313135A (en) * | 2016-07-21 | 2019-02-05 | 香港科技大学 | Aggregation-induced emission body for imaging cancerous |
CN109422707A (en) * | 2017-08-25 | 2019-03-05 | 香港科技大学 | Aggregation-induced emission lysosome probe and the preparation method and application thereof independent of acid pH |
Non-Patent Citations (3)
Title |
---|
QIANG WANG ET AL.: "Lysosome-Targeting Red-Emitting Aggregation-Induced Emission Probe with Large Stokes Shift for Light-Up in Situ Visualization of β‑N‑Acetylhexosaminidase", 《ANAL. CHEM.》 * |
XIUJUAN SHI ET AL.: "In vivo monitoring of tissue regeneration using a ratiometric lysosomal AIE probe", 《CHEM. SCI.》 * |
YUANJING CAI ET AL.: "An acidic pH independent piperazine–TPE AIEgen as a unique bioprobe for lysosome tracing", 《CHEM. SCI.》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112851575B (en) | 2022-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103087545B (en) | Fluorochrome taking fluorescein as matrix, as well as preparation method and application thereof | |
US5852191A (en) | Rigidized monomethine cyanines | |
JP5090731B2 (en) | Fluorescent probe | |
JP2021529194A (en) | Polymer dye with linker group containing deoxyribose | |
AU2006321854A1 (en) | Optical determination of glucose utilizing boronic acid adducts-II | |
JP6275689B2 (en) | Fluorescent probe | |
Fang et al. | An excited-state intramolecular proton transfer (ESIPT)-based aggregation-induced emission active probe and its Cu (II) complex for fluorescence detection of cysteine | |
US10837909B2 (en) | Super-resolution fluorescent imaging probe | |
Sui et al. | A BODIPY‐Based Water‐Soluble Fluorescent Probe for Mitochondria Targeting | |
Ambrosi et al. | PluS Nanoparticles as a tool to control the metal complex stoichiometry of a new thio-aza macrocyclic chemosensor for Ag (I) and Hg (II) in water | |
Reddy et al. | Luminescent Trimethoprim–Polyaminocarboxylate Lanthanide Complex Conjugates for Selective Protein Labeling and Time-Resolved Bioassays | |
WO2013131235A1 (en) | Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof | |
Hovor et al. | Water-soluble norsquaraine dyes for protein labeling and pH-sensing applications | |
CN113620963B (en) | Mitochondrial viscosity probe and preparation method and application thereof | |
US8129532B2 (en) | Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use | |
EP1976850B1 (en) | Novel lanthanide ligands and complexes, and use thereof as contrast agents | |
Connally et al. | Time‐resolved fluorescence microscopy using an improved europium chelate BHHST for the in situ detection of Cryptosporidium and Giardia | |
KR100976230B1 (en) | Two photon probe for real time monitoring of intracellular calcium ions, method for preparing the same and method for real time monitoring of intracellular calcium ions | |
Li et al. | Two pH-responsive fluorescence probes based on indole derivatives | |
CN112851575B (en) | Ratio type lysosome pH probe with aggregation-induced emission property and application | |
CN112694469B (en) | Pyrrosinyl-based HOCl fluorescent probe, and preparation method and application thereof | |
CN113563298A (en) | Water-soluble substituent-containing rhodamine fluorescent dye and preparation method and application thereof | |
EP2029673B1 (en) | Improved photostable fret-competent biarsenical-tetracysteine probes based on fluorinated fluoresceins | |
CN112321492A (en) | Fluorescent viscosity probe for monitoring mitophagy, preparation and application thereof | |
Rajasekar et al. | Recent developments in Photoresponse-based Zinc (II) sensors and Biomaterials/Biomedical Applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |